✦ LIBER ✦

23–valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial

✍ Scribed by N French; J Nakiyingi; LM Carpenter; E Lugada; C Watera; K Moi; M Moore; D Antvelink; D Mulder; EN Janoff; J Whitworth; CF Gilks

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of nine-valent pneumococcal con

✍ FT Cutts; SMA Zaman; G Enwere; S Jaffar; OS Levine; JB Okoko; C Oluwalana; A Vau 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 107 KB

Primary prophylaxis of cryptococcal dise

✍ Rosalind Parkes-Ratanshi; Katie Wakeham; Jonathan Levin; Deodata Namusoke; James 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 211 KB

Safety and immunogenicity of 23-valent p

✍ A Amendola; E Tanzi; A Zappa; D Colzani; A Boschini; D.M Musher; A.R Zanetti 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Effects of influenza vaccination in HIV-

✍ Sybil A Tasker; William A O'Brien; John J Treanor; Peter J Weiss; Patrick E Olso 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 541 KB

Randomized trial of the quantitative and

✍ Daniel R. Feikin; Cheryl M. Elie; Matthew B. Goetz; Jeffrey L. Lennox; George M. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 205 KB

Therapeutic immunisation with recombinan

✍ Eric Sandström; Britta Wahren 📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 117 KB